Iain Dukes - 09 Jun 2023 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Director
Signature
/s/ Mark Manfredi, as Attorney-in-Fact for Iain D. Dukes
Issuer symbol
IKNA
Transactions as of
09 Jun 2023
Net transactions value
$0
Form type
4
Filing time
13 Jun 2023, 16:30:27 UTC
Previous filing
08 Jun 2023
Next filing
13 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Award $0 +17,520 $0.000000 17,520 09 Jun 2023 Common Stock 17,520 $6.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full upon the earlier of (i) June 9, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.